Focus Taiwan App

Taiwanese research unit, Merck team up on new drug development

03/26/2018 09:39 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, March 26 (CNA) Taiwan's Industrial Technology Research Institute (ITRI) signed a memorandum of understanding (MOU) with German pharmaceutical and life science giant Merck on Monday on cooperation to developed advanced biopharma technologies.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.